(S)-2-Amino-2-(3-chloro-2-fluorophenyl)ethanol hydrochloride, 97.0%, 250mg

2-(4-Methoxyphenyl)-5,5-dimethyl-1,3,2-dioxaborinane, 97%, 5g

N,N'-Bis[4-di(m-tolyl)aminophenyl]-N,N'-diphenylbenzidine>98.0%(HPLC)1g

Methyl 3-Chloro-4-methylbenzoate, 97.0%, 100g

3-Oxoisoindoline-5-carboxylic acid, 95.0%, 100mg

Colonne capillaire GC ROTI®Cap-1, 50 m, 0,20 mm, 0,35 µm, 1 pièce(s)

(4-BROMO-3-METHYLPHENYL)(4-METHOXY-3-NITROPHENYL)METHANONE, 95.0%, 100mg

(4aS,7aS)-6-Benzyloctahydro-1H-pyrrolo[3,4-b]pyridine, 95%, 1g

N-(2-Chlorophenyl)-5-(methylsulfonyl)picolinamide, 97.0%, 250mg

1-(3,4-dichlorophenyl)-3-(ethoxycarbonyl)-5-methyl-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 2g

2-(2-Azaspiro[3.3]heptan-6-yl)acetic acid hydrochloride, 98%, 250mg

10,10-Dimethylanthracen-9(10H)-one>98.0%(GC)5g

2-{[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl}acetic acid, 97%, 1g